Pages that link to "Q43908612"
Jump to navigation
Jump to search
The following pages link to Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition (Q43908612):
Displaying 43 items.
- Recent developments and innovations in gastric cancer (Q26751327) (← links)
- Gastric cancer development after the successful eradication of Helicobacter pylori (Q26753852) (← links)
- Diagnosis and management of gastric dysplasia (Q26765128) (← links)
- Helicobacter pylori in gastric carcinogenesis (Q26774101) (← links)
- Gastric cancer: prevention, screening and early diagnosis (Q26860418) (← links)
- Diagnosis and management of high risk group for gastric cancer (Q28084323) (← links)
- Helicobacter pylori eradication for preventing gastric cancer (Q33626785) (← links)
- Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea (Q33735315) (← links)
- Optimal initiation of Helicobacter pylori eradication in patients with peptic ulcer bleeding (Q35128251) (← links)
- Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis. (Q35211999) (← links)
- Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer (Q35261353) (← links)
- Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective. (Q35598058) (← links)
- Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal. (Q36181286) (← links)
- Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations (Q36209645) (← links)
- Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication (Q36256381) (← links)
- Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy (Q36272074) (← links)
- Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication (Q36448524) (← links)
- Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial (Q37066366) (← links)
- Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer (Q37138735) (← links)
- Current progress toward eradicating Helicobacter pylori in East Asian countries: differences in the 2013 revised guidelines between China, Japan, and South Korea (Q37587260) (← links)
- Risk Factors for Metachronous Recurrence after Endoscopic Submucosal Dissection of Early Gastric Cancer (Q37622302) (← links)
- Current status of functional dyspepsia in Korea (Q37642189) (← links)
- Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition (Q38206548) (← links)
- Attempts to enhance the eradication rate of Helicobacter pylori infection (Q38212213) (← links)
- A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease (Q40255786) (← links)
- Is There Any Difference in the Eradication Rate of Helicobacter pylori Infection According to the Endoscopic Stage of Peptic Ulcer Disease? (Q41442357) (← links)
- Helicobacter pylori Eradication, a Gordian Knot for Idiopathic Thrombocytopenic Purpura? (Q42849849) (← links)
- Time to learn from the past and prepare for the future in Helicobacter pylori eradication. (Q43179536) (← links)
- Efficacy of hybrid therapy as first-line regimen for Helicobacter pylori infection compared with sequential therapy (Q44247194) (← links)
- Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial (Q47170175) (← links)
- Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance (Q51155865) (← links)
- A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea (Q51712832) (← links)
- Diagnosis of Infection in Children and Adolescents in Korea (Q57820600) (← links)
- Alternative eradication regimens for infection in Indonesian regions with high metronidazole and levofloxacin resistance (Q61805254) (← links)
- Vonoprazan and Treatment: A Lesson From Japan or a Limited Geographic Phenomenon? (Q64072046) (← links)
- Role of Upper Gastrointestinal Endoscopy in Patients with Human Immunodeficiency Virus Infection in the Era of Combination Antiretroviral Therapy (Q64119286) (← links)
- eradication in patients with type 2 diabetes mellitus: Multicenter prospective observational study (Q64264155) (← links)
- Comparison of 7- and 14-Day Eradication Therapy for Helicobacter pylori with First- and Second-Line Regimen: Randomized Clinical Trial (Q89588635) (← links)
- Hellenic consensus on Helicobacter pylori infection (Q90011065) (← links)
- Changes in the Treatment Strategies for Helicobacter pylori Infection in Children and Adolescents in Korea (Q90292459) (← links)
- Two-week bismuth-containing quadruple therapy and concomitant therapy are effective first-line treatments for Helicobacter pylori eradication: A prospective open-label randomized trial (Q92133507) (← links)
- Fermented milk containing Lactobacillus paracasei and Glycyrrhiza glabra has a beneficial effect in patients with Helicobacter pylori infection: A randomized, double-blind, placebo-controlled study (Q92978813) (← links)
- Helicobacter pylori eradication affects platelet count recovery in immune thrombocytopenia (Q96303340) (← links)